Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    7759696 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Harvard Atherosclerosis Reversibility Project (HARP)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Drug: pravastatin;   Drug: niacin;   Drug: cholestyramine;   Drug: gemfibrozil;   Drug: fatty acids, omega-3

Study has passed its completion date and status has not been verified in more than two years.